Leber- und Gallentumore | ICD10: C22-C24

151 KB  

eine multizentrische, randomisierte, kontrollierte Phase III Studie- adjuvante Chemotherapie mit Gemcitabin und Cisplatin bei Patienten mit Gallengangskrebs nach kompletter chirurgischer Entfernung

156 KB  

A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab Versus Placebo for Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation

84 KB  

A 12-month, Open-label, Multicenter, Randomized, Safety, Efficacy, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of an Anti-CD40 Monoclonal Antibody, CFZ533 vs. Standard of Care Control, in Adult de Novo Liver Transplant Recipients With a 12-month Additional Follow-up (CONTRAIL I)

95 KB  

Investigate the use of DSM-TACE in a large-scale, collaborative, non-interventional study

169 KB  

An Open-label, Single-arm Phase II Study of Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular

54 KB  

Trial to Evaluate the Safety of Talimogene Laherparepvec Injected into Liver Tumors Alone and in Combination With Systemic Pembrolizumab

94 KB  

A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma and Complete Radiological Response After Surgical Resection or Local Ablation (KEYNOTE-937)

82 KB  

A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma